Let's spread the word about Immunotherapy! Click to share this page with your community.

Understanding Genomics and Genetic Testing in Cancer Immunotherapy

Above all, cancer is a disease of mutations. Some of these are inherited, while others are acquired throughout an individual’s life. While these mutations drive the tumor growth and survival, they may also holds the key to cures for more patients. In addition to guiding decisions regarding existing treatments, the mutated proteins that arise from genetic mutations can also serve as targets for the immune system and personalized immunotherapy strategies.

In this webinar for patients and caregivers, our expert discusses the current state of genetic testing for cancer patients in the clinic as well as highlights efforts to tap into the full potential of genome-based medicine.

Expert to be announced shortly. 

The "Cancer Immunotherapy and You" webinar series is produced by the Cancer Research Institute and is hosted by our science writer, Arthur Brodsky, Ph.D. The 2020 series is made possible with generous support from Bristol-Myers Squibb and Foundation Medicine.
Browse our Cancer Immunotherapy and You Webinar Series playlist on YouTube or visit the Webinars page on our website to see other webinars in this series.

Bristol-Myers Squibb and Foundation Medicine

*Immunotherapy results may vary from patient to patient.